The Clinical Use and Insurance of Biosimilars in the US ——Taking the Pfizer vs. Johnson Lawsuit as an Example
DONG Xin-yue,JIANG Rong,LIZHA Adelietibieke,SHAO Rong
China Biotechnology . 2019, (12): 95 -102 .  DOI: 10.13523/j.cb.20191212